• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Disclaimer

The content of the International Alliance of ALS/MND Associations’ (“the Alliance”) web site is provided for information purposes only. Appropriately qualified and experienced people have reviewed the content to support its accuracy. The Alliance does not accept any liability to any person for the information or advice (or the use of such information or advice) that is provided on this web site or incorporated into it by reference. The information on the Alliance web site is provided on the basis that all persons accessing the site undertake responsibility for assessing the relevance and accuracy of its content for their own purposes.

The Alliance has initiated a policy by which Alliance members can link their sites to the Alliance web site. The Alliance expects that the information contained on the member’s site has been peer reviewed by appropriately qualified and experienced people to support its content and accuracy.

No liability or responsibility is taken by the Alliance for any information or services that may appear on any linked web sites.

Primary Sidebar

  • Catherine Pearce, Australia

    Catherine Pearce, Australia

  • Ann Nicol, USA

    Ann Nicol, USA

  • Lombana, Spain

    Lombana, Spain

  • Mark Miller, UK

    Mark Miller, UK

  • Ching-Liang Chu, Taiwan

    Ching-Liang Chu, Taiwan

  • Yessenia Hernandez Mendoza, Mexico

    Yessenia Hernandez Mendoza, Mexico

  • Susan Keldani, USA

    Susan Keldani, USA

  • Animesh Kumar, India

    Animesh Kumar, India

  • David Watson, Scotland

    David Watson, Scotland

  • Phil Rossall, UK

    Phil Rossall, UK

  • Malcolm Buck, Australia

    Malcolm Buck, Australia

  • Soledad Rodriguez, Spain

    Soledad Rodriguez, Spain

  • Nicholas (Nic) Bowman, South Africa

    Nicholas (Nic) Bowman, South Africa

  • Osiel Mendoza, USA

    Osiel Mendoza, USA

  • Andrietta, Italy

    Andrietta, Italy
    Andrietta

  • JP

    JP

  • Eddy LeFrançois, Canada

    Eddy LeFrançois, Canada

  • Orly Dichoso, Canada

    Orly Dichoso, Canada

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Angelique van der Lit-van Veldhuizen, Netherlands

    Angelique van der Lit-van Veldhuizen, Netherlands

  • Dr. Shelly Hoover, USA

    Dr. Shelly Hoover, USA

  • Jeff Sutherland, Canada

    Jeff Sutherland, Canada
    jspic

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • Claudia Gotti, Brazil

    Claudia Gotti, Brazil

  • Art Eggert, USA

    Art Eggert, USA

  • Ismail Gokcek, Turkey

    Ismail Gokcek, Turkey
    ismail_gokcek_alsmnd_tr

  • Carlos Gomez Matallanas, Spain

    Carlos Gomez Matallanas, Spain

  • Willi Klein, UK

    Willi Klein, UK

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • Philip Brindle, England

    Philip Brindle, England

  • Semra Gokalp, Turkey

    Semra Gokalp, Turkey

  • Ian Gale, Australia

    Ian Gale, Australia

  • Andres Estevez Guersznik, Ireland

    Andres Estevez Guersznik, Ireland

  • Den Haag, Netherlands

    Den Haag, Netherlands

  • Mona H. Bahus and Camilla Knoff Glomstad, Norway

    Mona H. Bahus and Camilla Knoff Glomstad, Norway

  • Kirsty Gerlach, New Zealand

    Kirsty Gerlach, New Zealand

  • Lee Millard, England

    Lee Millard, England

  • Timmy, Belgium

    Timmy, Belgium

  • Camilla Heiberg Freiberg, Denmark

    Camilla Heiberg Freiberg, Denmark

  • Anderson Custodio Pinto, Brazil

    Anderson Custodio Pinto, Brazil

  • Manuel Arn, Switzerland

    Manuel Arn, Switzerland

  • Richard Clark, New Zealand

    Richard Clark, New Zealand

  • Anita Forte, USA

    Anita Forte, USA

  • Orlando Ruiz, Colombia

    Orlando Ruiz, Colombia

  • Ali Var, Turkey

    Ali Var, Turkey

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Andrew Langat, Kenya

    Andrew Langat, Kenya

  • Glen Victor Peters, Australia

    Glen Victor Peters, Australia

  • Maurice Leclerc, Canada

    Maurice Leclerc, Canada

  • Jan Zuring, Netherlands

    Jan Zuring, Netherlands

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login